Safety, Tolerability, and Pharmacokinetics of PTI-808, PTI-801, and PTI-428 Combination Therapy in Subjects With Cystic Fibrosis
Clinical trial NCT03500263 · COMPLETED
Trial details
- NCT number
- NCT03500263
- Sponsor
- Proteostasis Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-30
- Primary completion
- 2019-03-13
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.